Systemic vs. intrathecal central nervous system prophylaxis in primary adrenal/renal diffuse large b-cell Lymphoma: A multi-institution retrospective analysis and systematic review

Autor: Xie, John, Jang, Albert, Uemura, Motohide, Nakazawa, Shigeaki, Calimeri, Teresa, Ferreri, Andres JM, Chen, Shuang R., Schmid, Janet L., Brown, Theresa C., Socola, Francisco, Safah, Hana, Saba, Nakhle S.

Publikováno v: In Leukemia Research Reports 2021 16

Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy

Autor: Liu, Zhiyu, Xu-Monette, Zijun Y, Cao, Xin, Manyam, Ganiraju C, Wang, Xiaoxiao, Tzankov, Alexandar, Xia, Yi, Li, Xin, Visco, Carlo, Sun, Ruifang, Zhang, Li, Montes-Moreno, Santiago, Dybkær, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L, Hsi, Eric D, Choi, William WL, van Krieken, J Han, Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés JM, Parsons, Ben M, Møller, Michael B, Piris, Miguel A, Winter, Jane N, O'Malley, Dennis P, Medeiros, L Jeffrey, Young, Ken H

Publikováno v: In Modern Pathology October 2015 28(10):1297-1314

A narrative review of consolidation strategies for young and fit patients with newly-diagnosed primary central nervous system lymphoma

Autor: Sara Steffanoni, Teresa Calimeri, Nicoletta Anzalone, Sara Mastaglio, Massimo Bernardi, Andrés JM Ferreri

Publikováno v: Expert review of hematology. 15(1)

The modern treatment of patients with primary central nervous system lymphoma (PCNSL) consists of two phases: induction, currently represented by a high-dose-methotrexate-based polychemotherapy, and consolidation. The optimal consolidation therapy ha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca39de7b0184897bef45d535fe8e6147
https://pubmed.ncbi.nlm.nih.gov/34904506

Efficacy and Safety of Tisagenlecleucel in Adult Patients with Relapsed/Refractory Follicular Lymphoma: Interim Analysis of the Phase 2 Elara Trial

Autor: Fowler, Nathan H, Dickinson, Michael, Dreyling, Martin, Martinez-Lopez, Joaquin ^*, Kolstad, Arne ^*, Butler, Jason P, Ghosh, Monalisa, Popplewell, Leslie L., Chavez, Julio C., Bachy, Emmanuel ^*, Kato, Koji, Harigae, Hideo, Kersten, Marie José, Andreadis, Charalambos, Riedell, Peter A., Ho, P. Joy, Pérez-Simón, Jose Antonio ^*, Nagle, Sarah J., Nastoupil, Loretta J., von Tresckow, Bastian ^*, Ferreri, Andres JM, Teshima, Takanori, Patten, Piers, McGuirk, Joseph P., Petzer, Andreas, Offner, Fritz C., Viardot, Andreas, Zinzani, Pier Luigi, Malladi, Ram ^*, Bubuteishvili Pacaud, Lida ^*, Forcina, Alessandra ^*, Zia, Aiesha ^*, Schuster, Stephen J., Thieblemont, Catherine

Publikováno v: In Blood 5 November 2020 136 Supplement 1:1-3

Avoidable Adverse Events Related to Ignoring the Do-Not-Do Recommendations: A Retrospective Cohort Study Conducted in the Spanish Primary Care Setting

Autor: Mira JJ, Carrillo I, Pérez-Pérez P, Astier-Peña MP, Caro-Mendivelso J, Olivera G, Silvestre C, Nuín MA, Aranaz-Andrés JM, on behalf the SOBRINA Research Team

Publikováno v: JOURNAL OF PATIENT SAFETY
r-FISABIO. Repositorio Institucional de Producción Científica
instname
J PATIENT SAF
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)

OBJECTIVE: This study aimed to measure the frequency and severity of avoidable adverse events (AAEs) related to ignoring do-not-do recommendations (DNDs) in primary care. METHODS: A retrospective cohort study analyzing the frequency and severity of A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::cec520bae03aa845fa01616f3bff1e47
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=9458